|
CN112216384A
|
|
Diabetic nephropathy risk assessment system
|
|
CN112259221A
|
|
Lung cancer diagnosis system based on multiple machine learning algorithms
|
|
CN111939274A
|
|
Application of perfluorooctane sulfonate in establishment of bronchopulmonary dysplasia animal model
|
|
CN112219794A
|
|
Method for establishing bronchopulmonary dysplasia animal model by using perfluorooctanoic acid
|
|
CN112043837A
|
|
Application of MiR-205-5p in preparation of angiogenesis agent
|
|
CN112062695A
|
|
Prostate specific membrane antigen targeted inhibitor, application and probe
|
|
CN111933233A
|
|
Method and device for improving outpatient service efficiency by utilizing hospital local area network
|
|
CN111481342A
|
|
Ophthalmic stapler and method of using same
|
|
CN111534109A
|
|
Platelet factor 4 protein/polyvinyl sulfonic acid compound and preparation method and application thereof
|
|
CN111407400A
|
|
Non-invasive bipolar coagulation clamp for robot surgery and surgical robot
|
|
CN111489766A
|
|
System for testing and evaluating speech emotion recognition capability of Mandarin Chinese
|
|
CN111493883A
|
|
Chinese language repeating-memory speech cognitive function testing and evaluating system
|
|
CN111233758A
|
|
PSMA inhibitor, application thereof and nuclear species imaging reagent targeting PSMA
|
|
CN111281608A
|
|
Module for repairing cartilage defect and forming method thereof
|
|
CN111166416A
|
|
Lower uterine segment hemostasis structure for caesarean section
|
|
CN111235221A
|
|
Method for detecting activity of FAP inhibitor
|
|
WO2020156345A1
|
|
Psma inhibitor, compound and application
|
|
CN111012515A
|
|
Hip pad for lithotomy position operation
|
|
CN110711007A
|
|
Injection device for protective embolic agent in transvascular cavity
|
|
CN110680336A
|
|
Quantitative evaluation equipment and quantitative evaluation method for spasm
|
